Skip to main content

MedTech, diagnostic, SaMD, combination-product, and pharmaceutical innovators

Innovator Venture Room

Turn one secure intake into traceable decisions, a living commercialization blueprint, and disclosure you control.

Product definition

Core experience

What the environment does

The Venture Room is where a project is created, evidenced, decided, and selectively shared. You submit material once, confirm the facts that matter, and then work against decisions rather than documents. Raw data and project IP remain yours throughout, and nothing reaches an investor, expert, or partner without your explicit approval.

End to end

The experience, step by step

Each step produces a recorded artifact, so the sequence is auditable rather than merely descriptive.

  1. 01

    Create a project

    Name the product, the decision you are trying to make, and the jurisdictions you intend to enter. The project becomes the container for every later decision.

  2. 02

    Accept rights, consent, and data-processing terms

    Purpose, data rights, retention, and processing terms are presented and accepted before any file is analyzed. Acceptance is recorded with the project.

  3. 03

    Drag and drop files

    Protocols, decks, specifications, test reports, correspondence, and prior analyses are uploaded together. Files are scanned, parsed in a sandbox, hashed, and receipted.

  4. 04

    Add structured product information

    Guided fields capture what documents rarely state cleanly: stage, team, capital position, target launch, and the decision currently blocked.

  5. 05

    Confirm the definition of the product

    Intended use, patient population, user, mechanism, jurisdiction, and claims are presented for explicit confirmation, because every downstream stage depends on them.

  6. 06

    Review extracted facts and evidence

    Each extracted fact is shown with its source span, so you approve, correct, or reject it before any analysis relies on it.

  7. 07

    Resolve evidence gaps

    Gaps and contradictions are ranked by the decision they block, with the specific artifact that would close each one.

  8. 08

    Read separate readiness dimensions

    Safety, regulatory, IP, evidence, engineering, manufacturing, reimbursement, commercial, and capital readiness are reported separately, never merged into one score.

  9. 09

    Receive a decision

    Each stage returns GO, CONDITIONAL GO, HOLD, PIVOT, STOP, or ABSTAIN, with conditions, reasoning, evidence, and the approver the decision requires.

  10. 10

    Receive the highest-value next experiment

    For HOLD and PIVOT states, the experiment most likely to change the decision per dollar and unit of time is identified, with its cost and duration range.

  11. 11

    Build a living commercialization blueprint

    Approved decisions assemble into an execution-ready blueprint covering pathway, evidence plan, design controls, manufacturing readiness, capital milestones, and sequencing. It updates as decisions change rather than aging as a static deck.

  12. 12

    Create a controlled data room

    Assemble a disclosure package from approved material, choosing what is shown in full, what is summarized, and what stays private.

  13. 13

    Grant or revoke access

    Investor, expert, and partner access is scoped, logged, and revocable at any time, with every view recorded in the audit trail.

Capabilities

What you work with day to day

Project home

Decision sought, current stage, readiness vector, evidence completeness, and open blockers in one view.

Gate timeline

Completed, current, and conditional future gates, with the conditions attached to each.

Evidence gaps and contradictions

Priority gaps and conflicts surfaced with the source spans that produced them.

P50/P80 cost and schedule

Distributions with assumptions and sensitivity drivers, never a single deterministic number.

Living blueprint

An execution-ready plan that re-issues affected sections when a decision changes.

Disclosure control

Investor readiness and disclosure state remain under explicit project approval.

Boundaries

What this environment will not do

  • Critical extracted facts require your confirmation before downstream use.
  • You retain raw data and project IP; Decidian holds a processing right, not ownership.
  • No investor, expert, or partner sees anything until you approve a disclosure package.
  • Decidian does not perform regulatory signoff, legal opinions, engineering builds, testing, or quality release.

Acceptance criteria

How we judge it as built

  • Every material conclusion in the Venture Room links to its source spans.
  • Confirmed product-definition facts are versioned, and changing them invalidates dependent decisions.
  • Readiness is never displayed as a single composite score.
  • Access grants and revocations appear in the audit trail within the same session.

Explore the Innovator Venture Room

Access is role-based and scoped. We confirm authority and conflicts before granting a workspace.

Request an innovator walkthrough